Pharmacogenetics News and Research

RSS
The terms pharmacogenomics and pharmacogenetics are often used interchangeably to describe a field of research focused on how genes affect individual responses to medicines. Whether a medicine works well for you—or whether it causes serious side effects—depends, to a certain extent, on your genes.

Just as genes contribute to whether you will be tall or short, black-haired or blond, your genes also determine how you will respond to medicines. Genes are like recipes—they carry instructions for making protein molecules. As medicines travel through your body, they interact with thousands of proteins. Small differences in the composition or quantities of these molecules can affect how medicines do their jobs.

These differences can be due to diet, level of activity, or the medicines a person takes, but they can also be due to differences in genes. By understanding the genetic basis of drug responses, scientists hope to enable doctors to prescribe the drugs and doses best suited for each individual.
Pathway Genomics' personal Genetic Health Report now available

Pathway Genomics' personal Genetic Health Report now available

AssureRx Health adds CYP1A2 gene to laboratory-developed pharmacogenetic test

AssureRx Health adds CYP1A2 gene to laboratory-developed pharmacogenetic test

Unexplained, sudden anemia: Brown recluse spider bite

Unexplained, sudden anemia: Brown recluse spider bite

LGL awards first three grants from POC fund for research in immunotherapy, schizophrenia and heart disease

LGL awards first three grants from POC fund for research in immunotherapy, schizophrenia and heart disease

AutoGenomics launches expanded test panel to detect 17 B-RAF mutations

AutoGenomics launches expanded test panel to detect 17 B-RAF mutations

Two genetic alterations linked to benign enzyme condition keep hepatitis C patients anemia-free

Two genetic alterations linked to benign enzyme condition keep hepatitis C patients anemia-free

AutoGenomics awarded ISO 13485 certification for quality management system

AutoGenomics awarded ISO 13485 certification for quality management system

"Knowledge deficit" about methadone responsible for resulting deaths

"Knowledge deficit" about methadone responsible for resulting deaths

ESF-UB Conference to concentrate on potentially clinically relevant polymorphisms

ESF-UB Conference to concentrate on potentially clinically relevant polymorphisms

New pharmacology textbook released by Elsevier

New pharmacology textbook released by Elsevier

Beta 2 adrenergic agonist drugs linked to autism-spectrum disorders

Beta 2 adrenergic agonist drugs linked to autism-spectrum disorders

Beta 2 adrenergic agonist drugs can increase risk of autism-spectrum disorders in developing fetus

Beta 2 adrenergic agonist drugs can increase risk of autism-spectrum disorders in developing fetus

London Genetics enters an intensive partnering programme

London Genetics enters an intensive partnering programme

IPIT uses Affymetrix’s DMET Plus biomarker panel to expand the PGENI

IPIT uses Affymetrix’s DMET Plus biomarker panel to expand the PGENI

Clinical trial helps improve prognosis and changes the standard of care for patients with colorectal cancer

Clinical trial helps improve prognosis and changes the standard of care for patients with colorectal cancer

PIKAMAB obtains U.S. patent rights to develop theragnostic product

PIKAMAB obtains U.S. patent rights to develop theragnostic product

Diagnocure signs agreement with Lab21 for marketing its Previstage test

Diagnocure signs agreement with Lab21 for marketing its Previstage test

ASHG 2009 Annual Meeting to discuss the cutting-edge developments in human genetics and genomics research

ASHG 2009 Annual Meeting to discuss the cutting-edge developments in human genetics and genomics research

Discovery of inherited gene variants that account for 37 percent of childhood acute lymphoblastic leukemia

Discovery of inherited gene variants that account for 37 percent of childhood acute lymphoblastic leukemia

Discovery of genetic markers to help fight diabetes

Discovery of genetic markers to help fight diabetes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.